Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
39 participants
INTERVENTIONAL
2011-11-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Subjects that completed the ATLAST Study
Attune Sleep Apnea System
Observation of Attune Sleep Apnea System for use during sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attune Sleep Apnea System
Observation of Attune Sleep Apnea System for use during sleep.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject understands the Study protocol and is willing and able to comply with Study requirements and sign the informed consent form.
* The study physician and investigator believe that study participation is appropriate for the subject.
* Subject has at least one molar in each of the four quadrants of the mouth (right upper, right lower, left upper, and left lower).
Exclusion Criteria
* Poor nasal patency as evidenced by the inability to breathe through the nose with the mouth closed.
* Oral cavity infection or any other oral or dental condition or problem that would limit subject use of the Attune Sleep Apnea System
* History of any OSA surgical treatment
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ApniCure, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ian Colrain, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford Research Institute (SRI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
REM Medical
Phoenix, Arizona, United States
Penninsula Sleep Center (PSC)
Burlingame, California, United States
SRI International
Menlo Park, California, United States
Sleep Disorders Center of Georgia
Atlanta, Georgia, United States
SleepMed
Columbia, South Carolina, United States
Sleep Medicine Associates of Texas (SMAT)
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11449
Identifier Type: -
Identifier Source: org_study_id